Skip to main content
MANNKIND CORP logo

MANNKIND CORP — Investor Relations & Filings

Ticker · MNKD ISIN · US56400P7069 LEI · 213800GFBCNY1ZFST722 US Manufacturing
Filings indexed 1,205 across all filing types
Latest filing 2014-07-01 Regulatory Filings
Country US United States of America
Listing US MNKD

About MANNKIND CORP

https://mannkindcorp.com/

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products and devices. The company specializes in inhaled therapies for patients with cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza®, an inhaled insulin for diabetes, and Tyvaso DPI®, a dry powder inhaler for pulmonary hypertension developed in collaboration with United Therapeutics. Through its acquisition of scPharmaceuticals, MannKind also markets FUROSCIX®, a subcutaneous treatment for edema in adults with chronic heart failure. The company's pipeline is focused on expanding indications for its existing products, including a pediatric application for Afrezza.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 27, 2014. It announces the FDA approval of a product (AFREZZA) and includes a press release as an exhibit. The document does not contain financial statements or detailed financial data, nor is it an annual or quarterly report. It is a regulatory announcement of a significant event (FDA approval) rather than a financial report or management discussion. The document length is short (2371 characters), and it primarily serves as a regulatory filing to inform the market of a material event. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-07-01 English
FORM 4 SUBMISSION
Director's Dealing
2014-06-21 English
FORM 4 SUBMISSION
Director's Dealing
2014-06-18 English
FORM 4 SUBMISSION
Director's Dealing
2014-06-07 English
FORM 4 SUBMISSION
Director's Dealing
2014-06-07 English
FORM 4 SUBMISSION
Director's Dealing
2014-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.